We are live on ! Find out more
CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

Back to rankings

32 hedge funds and large institutions have $185M invested in Carisma Therapeutics in 2014 Q1 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
32
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRV
Third Rock Ventures
Massachusetts
+$72.5M
2
FV2GP
Flagship Ventures 2007 General Partner
Massachusetts
+$28.6M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$24.2M
4
Franklin Resources
Franklin Resources
California
+$14M
5
BC
Broadfin Capital
New York
+$12.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$156K +$144K +481 New
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$135K +$124K +415 New
TA
28
Teachers Advisors
New York
$75K +$69.2K +231 New
Morgan Stanley
29
Morgan Stanley
New York
$37K +$34.7K +116 New
Deutsche Bank
30
Deutsche Bank
Germany
$17K +$17.1K +57 New
Citigroup
31
Citigroup
New York
$6K +$4.79K +16 New
Barclays
32
Barclays
United Kingdom
$2K +$1.8K +6 New
1
2

CARM Hedge Fund Activity: Q1 2014 in Review

32 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q1 2014, worth a combined $185M.

Buyers outnumbered sellers: 32 funds opened new CARM positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Third Rock Ventures, opening a new position worth an estimated $72.5M.

  • 32 institutional investors held Carisma Therapeutics (CARM) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $185M of Carisma Therapeutics stock for Q1 2014.
  • 32 funds opened new Carisma Therapeutics positions in Q1 2014 and 0 closed out, a net change of +32 holders.
  • The largest Carisma Therapeutics buyer in Q1 2014 was Third Rock Ventures, an estimated $72.5M added.

Based on aggregated 13F filings for Q1 2014.